TO THE CONCERN PERSON — Daratumumab Importer Profile
Pharmaceutical Importer · #3 buyer for Daratumumab · $72.5K import value · 10 shipments · BRAZIL · DGFT Verified
TO THE CONCERN PERSON is the #3 importer of Daratumumab from India with $72.5K in import value and 10 verified shipments. TO THE CONCERN PERSON holds a 5.4% market share in Daratumumab imports based in BRAZIL. The company sources from 1 verified supplier across 10 formulations shipped to 1 country. Overall, TO THE CONCERN PERSON imports 4 pharmaceutical products worth $269.2K across 2 therapeutic categories.
TO THE CONCERN PERSON — Daratumumab Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Daratumumab to TO THE CONCERN PERSON?
Verified from 10 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NIVIRA EXPORTS | $72.5K | 10 | 100.0% |
TO THE CONCERN PERSON sources Daratumumab from 1 verified Indian supplier based on 10 customs records. The primary supplier is NIVIRA EXPORTS accounting for 100.0% of imports.
How Does TO THE CONCERN PERSON Compare to Nearest Daratumumab Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | AS PER INVOICE BRAZIL | BRAZIL | $93.8K | 12 | $7.8K |
| 2 | AS PER INVOICE AS | BRAZIL | $74.3K | 3 | $24.8K |
| 3 | TO THE CONCERN PERSON ★ | BRAZIL | $72.5K | 10 | $7.3K |
| 4 | EXP CODE | BRAZIL | $69.0K | 11 | $6.3K |
| 5 | IBL LTD-HEALTHACTIV | MAURITIUS | $55.1K | 3 | $18.4K |
TO THE CONCERN PERSON ranks #3 among 56 Daratumumab importers from India. Average shipment value of $7.3K compared to the market average of $10.3K. The closest competitors by value are AS PER INVOICE BRAZIL and AS PER INVOICE AS.
Where Does TO THE CONCERN PERSON Import Daratumumab To?
Destination countries from 10 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $72.5K | 10 | 100.0% |
TO THE CONCERN PERSON imports Daratumumab to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $72.5K.
What Daratumumab Formulations Does TO THE CONCERN PERSON Import?
| Formulation | Value | Shipments |
|---|---|---|
| MEDICINES-EACH 20 ML OF CONCENTRATE CONTAINS:DARATUMUMAB 400 MG BRAND NAME:DARZALEX 400 MG / 20 ML,BATCH NO:NCS5802(6 SESET | $8.9K | 1 |
| MEDICINES : DARATUMUMAB 400 MG BRAND ANME:DARZALEK 400 MG / 20 ML BATCH NO.NCS5802 (1 SETS) NDS2701 (9 SETS) | $7.7K | 1 |
| MEDICINES : EACH VIAL OF 20 ML CONCENTRATE CONTAINS: DARATUMUMAB 400 MG BRAND NAME: DARZALEX 400 MG/20 MLSET | $7.4K | 1 |
| MEDICINES : EACH VIAL OF 20 ML CONCENTRATE CONTAINS: DARATUMUMAB 400 MG BRAND NAME: DARZALEX 400 MG/20 ML BATCH NO:NGS6CSET | $7.4K | 1 |
| MEDICINES:EACH VIAL OF 20 ML CONCENTRATECONTAINS:DARATUMUMAB 400 MGBRAND NAME:DARZALEX 400 MG/20 ML BATCH NO:NDS2701(SET | $7.4K | 1 |
| MEDICINES:EACH VIAL OF 20 ML CONCENTRATECONTAINS:DARATUMUMAB 400 MG BRAND NAME:DARZALEX 400 MG /20 ML BATCH NO:NGS6C01SET | $7.4K | 1 |
| MEDICINES:EACH VIAL OF 20 ML CONCENTRATE CONTAINS:DARATUMUMAB 400 MG BRAND NAME:DARZALEX 400 MG /20 ML BATCH NO:NGS6C01SET | $7.4K | 1 |
| MEDICINES: EACH VIAL OF 20 ML CONCENTRATE CONTAINS : DARATUMUMAB 400 MG BRAND NAME: DARZALEX 400 MG /20 ML BATCH NO:NGS6SET | $7.4K | 1 |
| MEDICINES- EACH VIAL OF 20 ML CONCENTRATE CONTAINS:DARATUMUMAB 400 MG BRAND NAME: DARZALEX 400 MG / 20 ML BATCH NO: NGSET | $7.4K | 1 |
| MEDICINES : EACH VIAL OF 5 ML CONCENTRATE CONTAINS: DARATUMUMAB 100 MG BRAND NAME: DARZALEX 100 MG/5 ML BATCH NO: NCS3Z0SET | $4.1K | 1 |
TO THE CONCERN PERSON imports 10 distinct Daratumumab formulations from India. The top formulation is MEDICINES-EACH 20 ML OF CONCENTRATE CONTAINS:DARATUMUMAB 400 with 1 shipments worth $8.9K.
Regulatory Requirements: Importing Daratumumab into Brazil
What TO THE CONCERN PERSON and other importers must comply with to import Daratumumab from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Daratumumab
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Daratumumab from India and How Much Does TO THE CONCERN PERSON Import?
India exported $576.7K worth of Daratumumab through 209 shipments from 36 suppliers to 23 countries, serving 56 buyers globally. TO THE CONCERN PERSON imports $72.5K of this total, accounting for 5.4% of India's Daratumumab exports with 10 shipments from BRAZIL. This is verified from 10 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for TO THE CONCERN PERSON's Daratumumab Imports?
TO THE CONCERN PERSON's average Daratumumab order value is $7.3K per consignment, based on 10 shipments totaling $72.5K. TO THE CONCERN PERSON is based in BRAZIL and ranks #3 among all Daratumumab importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Daratumumab to TO THE CONCERN PERSON?
TO THE CONCERN PERSON sources Daratumumab from 1 verified Indian supplier: NIVIRA EXPORTS ($72.5K, 100.0%). This is based on 10 customs records.
How Does TO THE CONCERN PERSON Compare to Other Daratumumab Importers?
TO THE CONCERN PERSON ranks #3 among 56 Daratumumab importers from India with a 5.4% market share. The top 3 importers are AS PER INVOICE BRAZIL ($93.8K), AS PER INVOICE AS ($74.3K), TO THE CONCERN PERSON ($72.5K). TO THE CONCERN PERSON processed 10 shipments from BRAZIL.
What Other Advanced Oncology Products Does TO THE CONCERN PERSON Import?
TO THE CONCERN PERSON also imports these advanced oncology products. Each links to the detailed product page.
About TO THE CONCERN PERSON
TO THE CONCERN PERSON imports 4 products worth $269.2K. Beyond Daratumumab, top products include Osimertinib, Ustekinumab, Ibrutinib. View the complete TO THE CONCERN PERSON profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Daratumumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Daratumumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TO THE CONCERN PERSON matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TO THE CONCERN PERSON's capped import value divided by total capped export value for Daratumumab across all Indian exporters.
- 5.Verified Records: This page is backed by 10 individual customs records matching TO THE CONCERN PERSON importing Daratumumab, covering 10 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 23+ countries, 56+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Daratumumab Import Data for TO THE CONCERN PERSON
Access order-level details, pricing data, supplier connections, and competitive analysis for TO THE CONCERN PERSON's Daratumumab imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TO THE CONCERN PERSON
Full Company Profile →
4 products · $269.2K total trade · 2 categories
TO THE CONCERN PERSON × Daratumumab
Verified from customs records
Company Overview
Top Products by TO THE CONCERN PERSON
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TO THE CONCERN PERSON.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Daratumumab. For current order-level data, contact TransData Nexus.